Literature DB >> 12374627

A role for the myoglobin redox cycle in the induction of endothelial cell apoptosis.

Felice D'Agnillo1, Abdu I Alayash.   

Abstract

This study investigates the potential role of the ferric/ferryl redox cycle of myoglobin (Mb) in the development of endothelial cell injury. Bovine aortic endothelial cells were incubated with ferric Mb (0.5-100 micro M) in the presence or absence of low steady states of H(2)O(2) (3-4 micro M) generated by glucose oxidase (GOX). The reaction of ferric Mb with H(2)O(2) generated ferryl Mb as monitored spectrophotometrically. Ferryl Mb formation correlated with the induction of apoptosis as indicated by morphological criteria, caspase 3 activation, phosphatidylserine (PS) externalization, and nuclear condensation by Hoechst 33342 staining. The addition of ascorbate or catalase inhibited the formation of ferryl Mb and the onset of apoptosis, whereas apoptosis was enhanced in cells depleted of intracellular glutathione by pretreatment with buthionine sulfoximine. Mb and Mb/GOX suppressed cell cycle progression, but only Mb/GOX produced significant cell loss revealed by the accumulation of sub G1 events. These results suggest a role for the Mb redox cycle in the induction of endothelial cell apoptosis, which may be relevant in the pathophysiology of diseases characterized by the release of Mb from damaged muscle.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12374627     DOI: 10.1016/s0891-5849(02)01007-9

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  4 in total

1.  Ascorbate removes key precursors to oxidative damage by cell-free haemoglobin in vitro and in vivo.

Authors:  Jacqueline Dunne; Alexis Caron; Patrick Menu; Abdu I Alayash; Paul W Buehler; Michael T Wilson; Radu Silaghi-Dumitrescu; Beatrice Faivre; Chris E Cooper
Journal:  Biochem J       Date:  2006-11-01       Impact factor: 3.857

2.  Tyrosine residues as redox cofactors in human hemoglobin: implications for engineering nontoxic blood substitutes.

Authors:  Brandon J Reeder; Marie Grey; Radu-Lucian Silaghi-Dumitrescu; Dimitri A Svistunenko; Leif Bülow; Chris E Cooper; Michael T Wilson
Journal:  J Biol Chem       Date:  2008-08-26       Impact factor: 5.157

3.  Midazolam protects B35 neuroblastoma cells through Akt-phosphorylation in reactive oxygen species derived cellular injury.

Authors:  Won Seog Chong; Chang Lim Hyun; Min Kyu Park; Jeong Min Park; Hyun-Ouk Song; Taejin Park; Young Su Lim; Choon Kyu Cho; Po Soon Kang; Hee Uk Kwon
Journal:  Korean J Anesthesiol       Date:  2012-02-20

4.  Comparison of the oxidative reactivity of recombinant fetal and adult human hemoglobin: implications for the design of hemoglobin-based oxygen carriers.

Authors:  Michelle Simons; Svetlana Gretton; Gary G A Silkstone; Badri S Rajagopal; Victoria Allen-Baume; Natalie Syrett; Thoufieq Shaik; Nelida Leiva-Eriksson; Luca Ronda; Andrea Mozzarelli; Michael B Strader; Abdu I Alayash; Brandon J Reeder; Chris E Cooper
Journal:  Biosci Rep       Date:  2018-07-02       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.